# AUTO-GENERATED FILE - DO NOT EDIT
# Generated from dih_models/parameters.py
# Run: python tools/generate-variables-yml.py
#
# Use in QMD files with: {{< var param_name >}}
#

"accidents_death_rate": "<a href=\"/knowledge/references.qmd#cdc-leading-causes-death\"\
  \ class=\"parameter-link\" title=\"Accidental/unintentional injury death rate |\
  \ ✓ High confidence | Unit: deaths per 100,000 | Click to view source\">62.3</a>"
"action_time_invest_minutes": "<a href=\"/knowledge/solution/wishocracy.qmd#action-steps\"\
  \ class=\"parameter-link\" title=\"Time to invest (minutes) | ✓ High confidence\
  \ | Unit: minutes | Click to view calculation\">10</a>"
"action_time_recruit_minutes": "<a href=\"/knowledge/solution/wishocracy.qmd#action-steps\"\
  \ class=\"parameter-link\" title=\"Time to recruit others (minutes) | ✓ High confidence\
  \ | Unit: minutes | Click to view calculation\">15</a>"
"action_time_total_hours": "<a href=\"/knowledge/solution/wishocracy.qmd#action-steps\"\
  \ class=\"parameter-link\" title=\"Total action time in hours | ✓ High confidence\
  \ | Formula: MINUTES ÷ 60 | Unit: hours | Click to view calculation\">0.45</a>"
"action_time_total_hours_latex": "$$\nHours = 27 / 60 = 0.45 \\text{ hours}\n$$"
"action_time_total_minutes": "<a href=\"/knowledge/solution/wishocracy.qmd#action-steps\"\
  \ class=\"parameter-link\" title=\"Total time for all three actions | ✓ High confidence\
  \ | Formula: VOTE + INVEST + RECRUIT | Unit: minutes | Click to view calculation\"\
  >27</a>"
"action_time_total_minutes_latex": "$$\nTotalTime = 2 + 10 + 15 = 27 \\text{ minutes}\n\
  $$"
"action_time_vote_minutes": "<a href=\"/knowledge/solution/wishocracy.qmd#action-steps\"\
  \ class=\"parameter-link\" title=\"Time to vote (minutes) | ✓ High confidence |\
  \ Unit: minutes | Click to view calculation\">2</a>"
"alzheimers_death_rate": "<a href=\"/knowledge/references.qmd#cdc-leading-causes-death\"\
  \ class=\"parameter-link\" title=\"Alzheimer's disease death rate | ✓ High confidence\
  \ | Unit: deaths per 100,000 | Click to view source\">27.7</a>"
"alzheimer_cure_bounty_estimate": "<a href=\"/cure-bounty-estimates\" class=\"parameter-link\"\
  \ title=\"Estimated bounty value for Alzheimer's cure | ✓ High confidence | Unit:\
  \ USD | Click to view calculation\">$10B</a>"
"antibiotics_life_extension_years": "<a href=\"/knowledge/references.qmd#life-expectancy-gains-medical-advances\"\
  \ class=\"parameter-link\" title=\"Life extension from antibiotics (conservative\
  \ mid-range from 5-23 years) | ✓ High confidence | Unit: years | Click to view source\"\
  >10</a>"
"average_market_return_pct": "<a href=\"/knowledge/references.qmd#average-stock-market-return\"\
  \ class=\"parameter-link\" title=\"Average annual stock market return (10%) | ✓\
  \ High confidence | Unit: rate | Click to view source\">10%</a>"
"average_us_hourly_wage": "<a href=\"/knowledge/references.qmd#average-us-hourly-wage\"\
  \ class=\"parameter-link\" title=\"Average US hourly wage | ✓ High confidence |\
  \ Unit: USD/hour | Click to view source\">$30</a>"
"baseline_lives_saved_annual": "<a href=\"/knowledge/references.qmd#who-global-health-estimates-2024\"\
  \ class=\"parameter-link\" title=\"Baseline annual lives saved by pharmaceuticals\
  \ (conservative aggregate) | ~ Medium confidence | \U0001F4CA Peer-reviewed | Conservative\
  \ estimate | Updated: 2024 | Unit: deaths/year | Click to view source\">12</a>"
"benefit_drug_price_reduction_annual": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#price-reduction\"\
  \ class=\"parameter-link\" title=\"Annual benefit from R&D savings passed to consumers\
  \ | ✓ High confidence | Unit: USD/year | Click to view calculation\">$100B</a>"
"benefit_earlier_drug_access_annual": "<a href=\"/knowledge/appendix/economic-value-of-accelerated-treatments.qmd\"\
  \ class=\"parameter-link\" title=\"Annual benefit from 7-year drug access acceleration\
  \ | ✓ High confidence | Unit: USD/year | Click to view calculation\">$300B</a>"
"benefit_medical_research_acceleration_annual": "<a href=\"/knowledge/appendix/research-acceleration-model.qmd\"\
  \ class=\"parameter-link\" title=\"Annual benefit from 115x research capacity increase\
  \ | ✓ High confidence | Unit: USD/year | Click to view calculation\">$100B</a>"
"benefit_mental_health_annual": "<a href=\"/knowledge/appendix/dfda-qaly-model.qmd#mental-health\"\
  \ class=\"parameter-link\" title=\"Annual benefit from mental health treatment gap\
  \ reduction | ✓ High confidence | Unit: USD/year | Click to view calculation\">$75B</a>"
"benefit_prevention_annual": "<a href=\"/knowledge/appendix/dfda-qaly-model.qmd#prevention\"\
  \ class=\"parameter-link\" title=\"Annual benefit from economic viability of prevention\
  \ | ✓ High confidence | Unit: USD/year | Click to view calculation\">$100B</a>"
"benefit_rare_diseases_annual": "<a href=\"/knowledge/appendix/dfda-qaly-model.qmd#rare-diseases\"\
  \ class=\"parameter-link\" title=\"Annual benefit from orphan drug viability | ✓\
  \ High confidence | Unit: USD/year | Click to view calculation\">$400B</a>"
"biometric_verification_cost_per_user_high_usd": "<a href=\"/knowledge/references.qmd#kyc-biometric-verification-costs-2024\"\
  \ class=\"parameter-link\" title=\"Biometric KYC verification cost at medium volume\
  \ | ✓ High confidence | Updated: 2024 | Unit: USD/verification | Click to view source\"\
  >$0</a>"
"biometric_verification_cost_per_user_low_usd": "<a href=\"/knowledge/references.qmd#kyc-biometric-verification-costs-2024\"\
  \ class=\"parameter-link\" title=\"Biometric KYC verification cost at high volume\
  \ (300M+ scale) | ✓ High confidence | Updated: 2024 | Unit: USD/verification | Click\
  \ to view source\">$0</a>"
"book_reading_speed_wpm": "<a href=\"/knowledge/references.qmd#average-reading-speed\"\
  \ class=\"parameter-link\" title=\"Average reading speed (conservative for non-fiction)\
  \ | ✓ High confidence | Unit: words/minute | Click to view source\">200</a>"
"book_reading_time_hours": "<a href=\"/knowledge/solution/wishocracy.qmd#time-investment\"\
  \ class=\"parameter-link\" title=\"Time to read the entire book | ✓ High confidence\
  \ | Formula: (WORDS ÷ SPEED) ÷ 60 | Unit: hours | Click to view calculation\">14.3</a>"
"book_reading_time_hours_latex": "$$\nReadTime = \\frac{171,121 / 200}{60} \\approx\
  \ 14.3 \\text{ hours}\n$$"
"campaign_celebrity_endorsement": "<a href=\"/knowledge/economics/campaign-budget.qmd\"\
  \ class=\"parameter-link\" title=\"Celebrity and influencer endorsements | ✓ High\
  \ confidence | Unit: USD | Click to view calculation\">$15M</a>"
"campaign_community_organizing": "<a href=\"/knowledge/economics/campaign-budget.qmd\"\
  \ class=\"parameter-link\" title=\"Community organizing and ambassador program budget\
  \ | ✓ High confidence | Unit: USD | Click to view calculation\">$30M</a>"
"campaign_contingency": "<a href=\"/knowledge/economics/campaign-budget.qmd\" class=\"\
  parameter-link\" title=\"Contingency fund for unexpected costs | ✓ High confidence\
  \ | Unit: USD | Click to view calculation\">$50M</a>"
"campaign_defense_conversion": "<a href=\"/knowledge/economics/campaign-budget.qmd\"\
  \ class=\"parameter-link\" title=\"Defense industry conversion program | ✓ High\
  \ confidence | Unit: USD | Click to view calculation\">$50M</a>"
"campaign_defense_lobbyist_budget": "<a href=\"/knowledge/economics/campaign-budget.qmd\"\
  \ class=\"parameter-link\" title=\"Budget for co-opting defense industry lobbyists\
  \ | ✓ High confidence | Unit: USD | Click to view calculation\">$50M</a>"
"campaign_healthcare_alignment": "<a href=\"/knowledge/economics/campaign-budget.qmd\"\
  \ class=\"parameter-link\" title=\"Healthcare industry alignment and partnerships\
  \ | ✓ High confidence | Unit: USD | Click to view calculation\">$35M</a>"
"campaign_infrastructure": "<a href=\"/knowledge/economics/campaign-budget.qmd\" class=\"\
  parameter-link\" title=\"Campaign operational infrastructure | ✓ High confidence\
  \ | Unit: USD | Click to view calculation\">$20M</a>"
"campaign_legal_ai_budget": "<a href=\"/knowledge/economics/campaign-budget.qmd\"\
  \ class=\"parameter-link\" title=\"AI-assisted legal work budget | ✓ High confidence\
  \ | Unit: USD | Click to view calculation\">$50M</a>"
"campaign_legal_defense": "<a href=\"/knowledge/economics/campaign-budget.qmd\" class=\"\
  parameter-link\" title=\"Legal defense fund | ✓ High confidence | Unit: USD | Click\
  \ to view calculation\">$20M</a>"
"campaign_legal_work": "<a href=\"/knowledge/economics/campaign-budget.qmd\" class=\"\
  parameter-link\" title=\"Legal drafting and compliance work | ✓ High confidence\
  \ | Unit: USD | Click to view calculation\">$60M</a>"
"campaign_lobbying_eu": "<a href=\"/knowledge/economics/campaign-budget.qmd\" class=\"\
  parameter-link\" title=\"EU lobbying campaign budget | ✓ High confidence | Unit:\
  \ USD | Click to view calculation\">$40M</a>"
"campaign_lobbying_g20_millions": "<a href=\"/knowledge/economics/campaign-budget.qmd\"\
  \ class=\"parameter-link\" title=\"G20 countries lobbying budget | ✓ High confidence\
  \ | Unit: USD | Click to view calculation\">$35M</a>"
"campaign_lobbying_us": "<a href=\"/knowledge/economics/campaign-budget.qmd\" class=\"\
  parameter-link\" title=\"US lobbying campaign budget | ✓ High confidence | Unit:\
  \ USD | Click to view calculation\">$50M</a>"
"campaign_media_budget_max": "<a href=\"/knowledge/economics/campaign-budget.qmd\"\
  \ class=\"parameter-link\" title=\"Maximum mass media campaign budget | ✓ High confidence\
  \ | Unit: USD | Click to view calculation\">$1.00B</a>"
"campaign_media_budget_min": "<a href=\"/knowledge/economics/campaign-budget.qmd\"\
  \ class=\"parameter-link\" title=\"Minimum mass media campaign budget | ✓ High confidence\
  \ | Unit: USD | Click to view calculation\">$500M</a>"
"campaign_opposition_research": "<a href=\"/knowledge/economics/campaign-budget.qmd\"\
  \ class=\"parameter-link\" title=\"Opposition research and rapid response | ✓ High\
  \ confidence | Unit: USD | Click to view calculation\">$25M</a>"
"campaign_phase1_budget": "<a href=\"/knowledge/economics/campaign-budget.qmd\" class=\"\
  parameter-link\" title=\"Phase 1 campaign budget (Foundation, Year 1) | ✓ High confidence\
  \ | Unit: USD | Click to view calculation\">$200M</a>"
"campaign_phase2_budget": "<a href=\"/knowledge/economics/campaign-budget.qmd\" class=\"\
  parameter-link\" title=\"Phase 2 campaign budget (Scale & Momentum, Years 2-3) |\
  \ ✓ High confidence | Unit: USD | Click to view calculation\">$500M</a>"
"campaign_pilot_programs": "<a href=\"/knowledge/economics/campaign-budget.qmd\" class=\"\
  parameter-link\" title=\"Pilot program testing in small countries | ✓ High confidence\
  \ | Unit: USD | Click to view calculation\">$30M</a>"
"campaign_platform_development": "<a href=\"/knowledge/economics/campaign-budget.qmd\"\
  \ class=\"parameter-link\" title=\"Voting platform and technology development |\
  \ ✓ High confidence | Unit: USD | Click to view calculation\">$35M</a>"
"campaign_regulatory_navigation": "<a href=\"/knowledge/economics/campaign-budget.qmd\"\
  \ class=\"parameter-link\" title=\"Regulatory compliance and navigation | ✓ High\
  \ confidence | Unit: USD | Click to view calculation\">$20M</a>"
"campaign_scaling_prep": "<a href=\"/knowledge/economics/campaign-budget.qmd\" class=\"\
  parameter-link\" title=\"Scaling preparation and blueprints | ✓ High confidence\
  \ | Unit: USD | Click to view calculation\">$30M</a>"
"campaign_staff_budget": "<a href=\"/knowledge/economics/campaign-budget.qmd\" class=\"\
  parameter-link\" title=\"Campaign core team staff budget | ✓ High confidence | Unit:\
  \ USD | Click to view calculation\">$40M</a>"
"campaign_super_pac_budget": "<a href=\"/knowledge/economics/campaign-budget.qmd\"\
  \ class=\"parameter-link\" title=\"Super PAC campaign expenditures | ✓ High confidence\
  \ | Unit: USD | Click to view calculation\">$30M</a>"
"campaign_tech_partnerships": "<a href=\"/knowledge/economics/campaign-budget.qmd\"\
  \ class=\"parameter-link\" title=\"Tech industry partnerships and infrastructure\
  \ | ✓ High confidence | Unit: USD | Click to view calculation\">$25M</a>"
"campaign_treaty_implementation": "<a href=\"/knowledge/economics/campaign-budget.qmd\"\
  \ class=\"parameter-link\" title=\"Post-victory treaty implementation support |\
  \ ✓ High confidence | Unit: USD | Click to view calculation\">$40M</a>"
"campaign_viral_content_budget": "<a href=\"/knowledge/economics/campaign-budget.qmd\"\
  \ class=\"parameter-link\" title=\"Viral marketing content creation budget | ✓ High\
  \ confidence | Unit: USD | Click to view calculation\">$40M</a>"
"campaign_weekly_ad_cost_k": "<a href=\"/knowledge/economics/campaign-budget.qmd\"\
  \ class=\"parameter-link\" title=\"Weekly advertising cost for campaigns | ✓ High\
  \ confidence | Unit: USD/week | Click to view calculation\">$500K</a>"
"cancer_death_rate": "<a href=\"/knowledge/references.qmd#cdc-leading-causes-death\"\
  \ class=\"parameter-link\" title=\"Cancer death rate (all cancers) | ✓ High confidence\
  \ | Unit: deaths per 100,000 | Click to view source\">147</a>"
"cardiovascular_death_rate": "<a href=\"/knowledge/references.qmd#cdc-leading-causes-death\"\
  \ class=\"parameter-link\" title=\"Cardiovascular disease death rate (heart disease\
  \ + stroke) | ✓ High confidence | Unit: deaths per 100,000 | Click to view source\"\
  >201</a>"
"caregiver_annual_value_total": "<a href=\"/knowledge/references.qmd#unpaid-caregiver-hours-economic-value\"\
  \ class=\"parameter-link\" title=\"Total annual value of unpaid caregiving in US\
  \ | ✓ High confidence | Unit: USD/year | Click to view source\">$600B</a>"
"caregiver_cost_annual": "<span class=\"parameter-link\" title=\"parameters.CAREGIVER_COST_ANNUAL\
  \ - $6,000/year\">6,000</span>"
"caregiver_count_us": "<a href=\"/knowledge/references.qmd#unpaid-caregiver-hours-economic-value\"\
  \ class=\"parameter-link\" title=\"Number of unpaid caregivers in US | ✓ High confidence\
  \ | Unit: people | Click to view source\">38M</a>"
"caregiver_hours_per_month": "<a href=\"/knowledge/references.qmd#average-family-caregiving-hours\"\
  \ class=\"parameter-link\" title=\"Average monthly hours of unpaid family caregiving\
  \ in US | ✓ High confidence | Unit: hours/month | Click to view source\">20</a>"
"caregiver_hours_per_month_avg": "<span class=\"parameter-link\" title=\"parameters.CAREGIVER_HOURS_PER_MONTH_AVG\
  \ - ~110 hours/month\">110</span>"
"caregiver_hours_per_week_avg": "<a href=\"/knowledge/references.qmd#unpaid-caregiver-hours-economic-value\"\
  \ class=\"parameter-link\" title=\"Average weekly hours of unpaid caregiving (25-26\
  \ hours/week) | ✓ High confidence | Unit: hours/week | Click to view source\">25.5</a>"
"caregiver_value_per_hour": "<a href=\"/knowledge/references.qmd#unpaid-caregiver-hours-economic-value\"\
  \ class=\"parameter-link\" title=\"AARP valuation of caregiving per hour | ✓ High\
  \ confidence | Unit: USD/hour | Click to view source\">$17</a>"
"caregiver_value_per_hour_simple": "<a href=\"/knowledge/references.qmd#caregiver-replacement-cost\"\
  \ class=\"parameter-link\" title=\"Estimated replacement cost per hour of caregiving\
  \ | ✓ High confidence | Unit: USD/hour | Click to view source\">$25</a>"
"childhood_vaccination_annual_benefit": "<a href=\"/knowledge/references.qmd#/knowledge/economics/economics.qmd#better-than-the-best-charities\"\
  \ class=\"parameter-link\" title=\"Estimated annual global economic benefit from\
  \ childhood vaccination programs (measles, polio, etc.) | ✓ High confidence | Unit:\
  \ USD/year | Click to view source\">$15B</a>"
"childhood_vaccination_roi": "<a href=\"/knowledge/references.qmd#childhood-vaccination-roi\"\
  \ class=\"parameter-link\" title=\"Return on investment from childhood vaccination\
  \ programs | ✓ High confidence | Unit: ratio | Click to view source\">13</a>"
"combined_peace_health_dividends_annual_for_roi_calc": "<a href=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness.qmd#combined-dividends\"\
  \ class=\"parameter-link\" title=\"Combined peace and health dividends for ROI calculation\
  \ | ✓ High confidence | Formula: PEACE_DIVIDEND + R&D_SAVINGS | Unit: USD/year |\
  \ Click to view calculation\">$164B</a>"
"combined_peace_health_dividends_annual_for_roi_calc_latex": "$$\nCombined = \\$113.55B\
  \ + \\$50B = \\$163.55B\n$$"
"completed_trials_multiplier_actual": "<a href=\"/knowledge/appendix/research-acceleration-model.qmd#total-multiplier\"\
  \ class=\"parameter-link\" title=\"Actual completed trials multiplier (180x theoretical)\
  \ | ✓ High confidence | Unit: ratio | Click to view calculation\">180</a>"
"completed_trials_multiplier_conservative": "<a href=\"/knowledge/appendix/research-acceleration-model.qmd#conservative-multiplier\"\
  \ class=\"parameter-link\" title=\"Conservative completed trials multiplier accounting\
  \ for scale-up | ✓ High confidence | Formula: RESEARCH_ACCELERATION_MULTIPLIER |\
  \ Unit: ratio | Click to view calculation\">115</a>"
"completed_trials_multiplier_conservative_latex": "$$\nMultiplier_{conservative} =\
  \ 115\n$$"
"completed_trials_multiplier_theoretical_max": "<a href=\"/knowledge/appendix/research-acceleration-model.qmd#theoretical-maximum\"\
  \ class=\"parameter-link\" title=\"Theoretical maximum research capacity multiplier\
  \ (25×10×1.6×1.4) | ✓ High confidence | Formula: RECRUITMENT_SPEED × COMPLETION_SPEED\
  \ × COMPLETION_RATE × FUNDING | Unit: ratio | Click to view calculation\">560</a>"
"completion_rate_improvement_multiplier": "<a href=\"/knowledge/appendix/research-acceleration-model.qmd#completion-rates\"\
  \ class=\"parameter-link\" title=\"Completion rate improvement (1.6x from 60% →\
  \ 95%) | ✓ High confidence | Formula: DFDA_COMPLETION_RATE ÷ CURRENT_COMPLETION_RATE\
  \ | Unit: ratio | Click to view calculation\">1.6</a>"
"completion_rate_improvement_multiplier_latex": "$$\nCompletion_{mult} = \\frac{0.95}{0.60}\
  \ = 1.58 \\approx 1.6\n$$"
"conservative_scenario_roi": "<a href=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness.qmd#conservative-scenario\"\
  \ class=\"parameter-link\" title=\"Conservative scenario ROI (net benefit ÷ total\
  \ costs) | ✓ High confidence | Formula: NET_BENEFIT ÷ TOTAL_COSTS | Unit: ratio\
  \ | Click to view calculation\">189</a>"
"conservative_scenario_roi_latex": "$$\nROI_{conservative} = \\$74.6B / \\$0.393B\
  \ = 190:1\n$$"
"cost_of_delay_deaths_per_second": "<a href=\"/knowledge/problem/cost-of-war.qmd#cost-of-delay\"\
  \ class=\"parameter-link\" title=\"Preventable deaths per second from curable diseases\
  \ | ✓ High confidence | Formula: DAILY_DEATHS ÷ SECONDS_PER_DAY | Unit: deaths/second\
  \ | Click to view calculation\">1.74</a>"
"cost_of_delay_deaths_per_second_latex": "$$\nDelay_{deaths} = \\frac{150,000}{86,400}\
  \ \\approx 1.74\n$$"
"cost_of_delay_qaly_days_per_second": "<a href=\"/knowledge/problem/cost-of-war.qmd#cost-of-delay\"\
  \ class=\"parameter-link\" title=\"QALY-days lost per second of inaction | ✓ High\
  \ confidence | Formula: (QALYS_ANNUAL ÷ 365) ÷ SECONDS_PER_YEAR | Unit: QALY-days/second\
  \ | Click to view calculation\">8.04e-05</a>"
"cost_of_delay_qaly_days_per_second_latex": "$$\nDelay_{QALY} = \\frac{925,610 / 365}{31,557,600}\
  \ \\approx 0.00008\n$$"
"cost_per_life_investor_funded": "<a href=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness.qmd#alternative-icer\"\
  \ class=\"parameter-link\" title=\"Cost per life for investor-funded scenario |\
  \ ✓ High confidence | Unit: USD/life | Click to view calculation\">$-7</a>"
"cost_per_life_opportunity_cost": "<a href=\"/knowledge/appendix/1-percent-treaty-cost-effectiveness.qmd#alternative-icer\"\
  \ class=\"parameter-link\" title=\"Cost per life counting military spending opportunity\
  \ cost | ✓ High confidence | Unit: USD/life | Click to view calculation\">$-5</a>"
"current_active_trials": "<a href=\"/knowledge/references.qmd#active-clinical-trials-baseline\"\
  \ class=\"parameter-link\" title=\"Current active trials at any given time (3-5\
  \ year duration) | ✓ High confidence | Unit: trials | Click to view source\">10,000</a>"
"current_clinical_trial_participation_rate": "<a href=\"/knowledge/references.qmd#clinical-trial-participants\"\
  \ class=\"parameter-link\" title=\"Current clinical trial participation rate (0.06%\
  \ of population) | ✓ High confidence | Unit: rate | Click to view source\">0.06%</a>"
"current_completed_trials_per_year": "<a href=\"/knowledge/appendix/research-acceleration-model.qmd#current-capacity\"\
  \ class=\"parameter-link\" title=\"Current completed trials per year (trials × completion\
  \ rate) | ✓ High confidence | Formula: TRIALS_PER_YEAR × COMPLETION_RATE | Unit:\
  \ trials/year | Click to view calculation\">1,980</a>"
"current_completed_trials_per_year_latex": "$$\nCompleted_{current} = 3,300 \\times\
  \ 0.60 = 1,980\n$$"
"current_disease_patients_global": "<a href=\"/knowledge/references.qmd#global-burden-disease-2-4-billion\"\
  \ class=\"parameter-link\" title=\"Global population with chronic diseases | ✓ High\
  \ confidence | Unit: people | Click to view source\">2.40B</a>"
"current_drug_approvals_per_year": "<a href=\"/knowledge/references.qmd#global-new-drug-approvals-50-annually\"\
  \ class=\"parameter-link\" title=\"Average annual new drug approvals globally |\
  \ ✓ High confidence | Unit: drugs/year | Click to view source\">50</a>"
"current_patient_eligibility_rate": "<a href=\"/knowledge/references.qmd#clinical-trial-eligibility-rate\"\
  \ class=\"parameter-link\" title=\"Current patient eligibility rate for clinical\
  \ trials (0.2%) | ✓ High confidence | Unit: rate | Click to view source\">0.2%</a>"
"current_trials_per_year": "<a href=\"/knowledge/references.qmd#global-clinical-trials-per-year\"\
  \ class=\"parameter-link\" title=\"Current global clinical trials per year | ✓ High\
  \ confidence | Unit: trials/year | Click to view source\">3,300</a>"
"current_trial_abandonment_rate": "<a href=\"/knowledge/references.qmd#clinical-trial-abandonment-rate\"\
  \ class=\"parameter-link\" title=\"Current trial abandonment rate (40% never complete)\
  \ | ✓ High confidence | Unit: rate | Click to view source\">40%</a>"
"current_trial_completion_rate": "<a href=\"/knowledge/references.qmd#clinical-trial-completion-rate\"\
  \ class=\"parameter-link\" title=\"Current trial completion rate (60%) | ✓ High\
  \ confidence | Unit: rate | Click to view source\">60%</a>"
"current_trial_slots_available": "<a href=\"/knowledge/references.qmd#global-trial-participant-capacity\"\
  \ class=\"parameter-link\" title=\"Total trial slots available for 2.4B sick people\
  \ | ✓ High confidence | Unit: slots | Click to view source\">5.00M</a>"
"daily_cost_inefficiency": "<a href=\"/knowledge/solution/dfda.qmd#cost-of-delay\"\
  \ class=\"parameter-link\" title=\"Daily cost of healthcare system inefficiency\
  \ | ✓ High confidence | Unit: USD/day | Click to view calculation\">$327M</a>"
"dct_platform_funding_medium": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#analogous-rom\"\
  \ class=\"parameter-link\" title=\"Mid-range funding for commercial DCT platform\
  \ | ✓ High confidence | Unit: USD | Click to view calculation\">$500M</a>"
"deaths_during_reading_section": "<a href=\"/knowledge/solution/dfda.qmd#cost-of-delay\"\
  \ class=\"parameter-link\" title=\"Deaths from curable diseases during reading one\
  \ section | ✓ High confidence | Unit: deaths | Click to view calculation\">410</a>"
"death_spending_misallocation_factor": "<a href=\"/knowledge/problem/cost-of-war.qmd#misallocation\"\
  \ class=\"parameter-link\" title=\"Misallocation factor for spending on death vs\
  \ prevention | ✓ High confidence | Unit: ratio | Click to view calculation\">1,750</a>"
"defense_lobbying_annual": "<a href=\"/knowledge/references.qmd#lobbying-spend-defense\"\
  \ class=\"parameter-link\" title=\"Annual defense industry lobbying spending | ✓\
  \ High confidence | \U0001F4CA Peer-reviewed | Updated: 2024 | Unit: USD/year |\
  \ Click to view source\">$127M</a>"
"defense_sector_retention_pct": "<span class=\"parameter-definition\" title=\"Percentage\
  \ of budget defense sector keeps under 1% treaty | Unit: rate | Core definition\"\
  >99%</span>"
"dfda_active_trials": "<a href=\"/knowledge/appendix/research-acceleration-model.qmd#dfda-capacity\"\
  \ class=\"parameter-link\" title=\"Active trials at any given time (3-12 month duration)\
  \ | ✓ High confidence | Unit: trials | Click to view calculation\">200K</a>"
"dfda_annual_opex": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#opex-breakdown\"\
  \ class=\"parameter-link\" title=\"Total annual dFDA operational costs (sum of all\
  \ components: $15M + $10M + $8M + $5M + $2M) | ✓ High confidence | Formula: PLATFORM_MAINTENANCE\
  \ + STAFF + INFRASTRUCTURE + REGULATORY + COMMUNITY | Unit: USD/year | Click to\
  \ view calculation\">$40M</a>"
"dfda_annual_opex_latex": "$$\nOPEX_{total} = \\sum_{i=1}^{5} OPEX_i = 0.015 + 0.010\
  \ + 0.008 + 0.005 + 0.002\n$$"
"dfda_avoided_regulatory_delay_cost_annual": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#regulatory-delay-avoidance\"\
  \ class=\"parameter-link\" title=\"Annual economic value of regulatory delay costs\
  \ avoided by dFDA | ~ Medium confidence | Formula: DALYS_AVOIDED × VSLY | Unit:\
  \ USD/year | Click to view calculation\">$11.1T</a>"
"dfda_avoided_regulatory_delay_cost_annual_latex": "$$\nValue_{avoided} = 74M \\times\
  \ \\$150k = \\$11.1T\n$$"
"dfda_avoided_regulatory_delay_dalys_annual": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#regulatory-delay-avoidance\"\
  \ class=\"parameter-link\" title=\"Annual DALYs saved by dFDA eliminating regulatory\
  \ efficacy lag | ~ Medium confidence | Formula: ANNUAL_DALYS × AVOIDANCE_FRACTION\
  \ | Unit: DALYs/year | Click to view calculation\">74M</a>"
"dfda_avoided_regulatory_delay_dalys_annual_latex": "$$\nDALY_{avoided} = 77.9M \\\
  times 0.95 = 74M\n$$"
"dfda_completed_trials_per_year": "<a href=\"/knowledge/appendix/research-acceleration-model.qmd#dfda-capacity\"\
  \ class=\"parameter-link\" title=\"dFDA completed trials per year (capacity × completion\
  \ rate) | ✓ High confidence | Formula: CAPACITY × COMPLETION_RATE | Unit: trials/year\
  \ | Click to view calculation\">361K</a>"
"dfda_completed_trials_per_year_latex": "$$\nCompleted_{dFDA} = 380,000 \\times 0.95\
  \ = 361,000\n$$"
"dfda_drug_approvals_per_year_high": "<a href=\"/knowledge/appendix/research-acceleration-model.qmd#approval-projections\"\
  \ class=\"parameter-link\" title=\"Optimistic drug approvals estimate (40x current)\
  \ | ✓ High confidence | Formula: CURRENT_APPROVALS × 40 | Unit: approvals/year |\
  \ Click to view calculation\">2,000</a>"
"dfda_drug_approvals_per_year_high_latex": "$$\nApprovals_{high} = 50 \\times 40 =\
  \ 2,000\n$$"
"dfda_drug_approvals_per_year_low": "<a href=\"/knowledge/appendix/research-acceleration-model.qmd#approval-projections\"\
  \ class=\"parameter-link\" title=\"Conservative drug approvals estimate (20x current)\
  \ | ✓ High confidence | Formula: CURRENT_APPROVALS × 20 | Unit: approvals/year |\
  \ Click to view calculation\">1,000</a>"
"dfda_drug_approvals_per_year_low_latex": "$$\nApprovals_{low} = 50 \\times 20 = 1,000\n\
  $$"
"dfda_eligible_patients_global": "<a href=\"/knowledge/appendix/research-acceleration-model.qmd#eligible-population\"\
  \ class=\"parameter-link\" title=\"Global eligible patients with minimal exclusions\
  \ | ✓ High confidence | Formula: DISEASE_PATIENTS × ELIGIBILITY_RATE | Unit: people\
  \ | Click to view calculation\">1.20B</a>"
"dfda_eligible_patients_global_latex": "$$\nEligible_{dFDA} = 2.4B \\times 0.50 =\
  \ 1.2B\n$$"
"dfda_icer_per_qaly": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#dfda-icer-analysis\"\
  \ class=\"parameter-link\" title=\"dFDA Infrastructure ICER per QALY (net incremental\
  \ cost ÷ QALYs gained) | ✓ High confidence | Formula: (DFDA_ANNUAL_OPEX - DFDA_RD_GROSS_SAVINGS_ANNUAL)\
  \ × 1B ÷ GLOBAL_DFDA_QALYS_GAINED_ANNUAL | Unit: USD/QALY | Click to view calculation\"\
  >$-59.5K</a>"
"dfda_icer_per_qaly_latex": "$$\n\\text{ICER} = \\frac{\\text{Net Incremental Cost\
  \ (Annual)}}{\\text{QALYs Gained (Annual)}} = \\frac{-\\$49.96\\text{B}}{840{,}000\
  \ \\text{ QALYs}} = -\\$59{,}476 \\text{ per QALY}\n$$"
"dfda_large_trial_recruitment_months": "<a href=\"/knowledge/appendix/research-acceleration-model.qmd#recruitment-speed\"\
  \ class=\"parameter-link\" title=\"Months to recruit 10,000+ patients in dFDA system\
  \ | ✓ High confidence | Unit: months | Click to view calculation\">3</a>"
"dfda_large_trial_size": "<a href=\"/knowledge/appendix/research-acceleration-model.qmd#trial-sizes\"\
  \ class=\"parameter-link\" title=\"Large dFDA pragmatic trial size | ✓ High confidence\
  \ | Unit: participants | Click to view calculation\">10,000</a>"
"dfda_net_incremental_cost_annual": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#net-incremental-cost\"\
  \ class=\"parameter-link\" title=\"Net incremental cost for dFDA (operational costs\
  \ minus R&D savings) | ✓ High confidence | Formula: DFDA_ANNUAL_OPEX - DFDA_RD_GROSS_SAVINGS_ANNUAL\
  \ | Unit: USD/year | Click to view calculation\">$-50B</a>"
"dfda_net_incremental_cost_annual_latex": "$$\nNetCost = \\$0.040B - \\$50.0B = -\\\
  $49.96B\n$$"
"dfda_net_savings_annual": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#net-savings\"\
  \ class=\"parameter-link\" title=\"Annual net savings (gross savings minus operational\
  \ costs) | ✓ High confidence | Formula: GROSS_SAVINGS - ANNUAL_OPEX | Unit: USD/year\
  \ | Click to view calculation\">$50B</a>"
"dfda_net_savings_annual_latex": "$$\nSavings_{net} = \\$50B - \\$0.04B = \\$49.96B\n\
  $$"
"dfda_npv_adoption_ramp_years": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#adoption-curve\"\
  \ class=\"parameter-link\" title=\"Years to reach full dFDA adoption | ✓ High confidence\
  \ | Unit: years | Click to view calculation\">5</a>"
"dfda_npv_annual_opex": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#npv-costs\"\
  \ class=\"parameter-link\" title=\"dFDA core platform annual opex (midpoint of $11-26.5M)\
  \ | ✓ High confidence | Unit: USD/year | Click to view calculation\">$18.9M</a>"
"dfda_npv_annual_opex_total": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#npv-costs\"\
  \ class=\"parameter-link\" title=\"Total NPV annual opex (dFDA core + DIH initiatives)\
  \ | ✓ High confidence | Formula: DFDA_OPEX + DIH_OPEX | Unit: USD/year | Click to\
  \ view calculation\">$40M</a>"
"dfda_npv_annual_opex_total_latex": "$$\nC_{op} = \\$0.01895B + \\$0.02110B = \\$0.04005B\n\
  $$"
"dfda_npv_benefit": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#npv-benefit\"\
  \ class=\"parameter-link\" title=\"NPV of dFDA benefits with 5-year adoption ramp\
  \ (10-year horizon) | ✓ High confidence | Formula: Sum of discounted annual net\
  \ savings with linear adoption ramp | Unit: USD | Click to view calculation\">$249B</a>"
"dfda_npv_benefit_latex": "$$\nPV_{benefits} = \\sum_{t=1}^{10} \\frac{NetSavings\
  \ \\times \\min(t,5)/5}{(1+r)^t} \\approx \\$249.3B\n$$"
"dfda_npv_net_benefit_conservative": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#npv-net-benefit\"\
  \ class=\"parameter-link\" title=\"Conservative NPV benefit from dFDA R&D savings\
  \ (10-year discounted with adoption ramp) | ✓ High confidence | Formula: NPV of\
  \ net savings with 5-year linear adoption ramp | Unit: USD | Click to view calculation\"\
  >$249B</a>"
"dfda_npv_net_benefit_conservative_latex": "$$\nBenefit_{NPV} = \\sum_{t=1}^{10} \\\
  frac{NetSavings \\times \\min(t,5)/5}{(1+r)^t} \\approx \\$249.3B\n$$"
"dfda_npv_pv_annual_opex": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#npv-calculation\"\
  \ class=\"parameter-link\" title=\"Present value of annual opex over 10 years (NPV\
  \ formula) | ✓ High confidence | Formula: OPEX × [(1 - (1 + r)^-T) / r] | Unit:\
  \ USD | Click to view calculation\">$269M</a>"
"dfda_npv_pv_annual_opex_latex": "$$\nPV_{opex} = \\$0.04005B \\times \\frac{1 - 1.08^{-10}}{0.08}\
  \ \\approx \\$0.269B\n$$"
"dfda_npv_total_cost": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#npv-total-cost\"\
  \ class=\"parameter-link\" title=\"Total NPV cost (upfront + PV of annual opex)\
  \ | ✓ High confidence | Formula: UPFRONT + PV_OPEX | Unit: USD | Click to view calculation\"\
  >$538M</a>"
"dfda_npv_total_cost_latex": "$$\nTotalCost_{NPV} = \\$0.26975B + \\$0.269B \\approx\
  \ \\$0.54B\n$$"
"dfda_npv_upfront_cost": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#npv-costs\"\
  \ class=\"parameter-link\" title=\"dFDA core platform build cost | ✓ High confidence\
  \ | Unit: USD | Click to view calculation\">$40M</a>"
"dfda_npv_upfront_cost_total": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#npv-costs\"\
  \ class=\"parameter-link\" title=\"Total NPV upfront costs (dFDA core + DIH initiatives)\
  \ | ✓ High confidence | Formula: DFDA_BUILD + DIH_INITIATIVES | Unit: USD | Click\
  \ to view calculation\">$270M</a>"
"dfda_npv_upfront_cost_total_latex": "$$\nC_0 = \\$0.040B + \\$0.22975B = \\$0.26975B\n\
  $$"
"dfda_opex_community": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#opex-breakdown\"\
  \ class=\"parameter-link\" title=\"dFDA community support costs | ✓ High confidence\
  \ | Unit: USD/year | Click to view calculation\">$2.00M</a>"
"dfda_opex_infrastructure": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#opex-breakdown\"\
  \ class=\"parameter-link\" title=\"dFDA infrastructure costs (cloud, security) |\
  \ ✓ High confidence | Unit: USD/year | Click to view calculation\">$8.00M</a>"
"dfda_opex_platform_maintenance": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#opex-breakdown\"\
  \ class=\"parameter-link\" title=\"dFDA platform maintenance costs | ✓ High confidence\
  \ | Unit: USD/year | Click to view calculation\">$15M</a>"
"dfda_opex_regulatory": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#opex-breakdown\"\
  \ class=\"parameter-link\" title=\"dFDA regulatory coordination costs | ✓ High confidence\
  \ | Unit: USD/year | Click to view calculation\">$5.00M</a>"
"dfda_opex_staff": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#opex-breakdown\"\
  \ class=\"parameter-link\" title=\"dFDA staff costs (minimal, AI-assisted) | ✓ High\
  \ confidence | Unit: USD/year | Click to view calculation\">$10M</a>"
"dfda_patient_eligibility_rate": "<span class=\"parameter-definition\" title=\"dFDA\
  \ patient eligibility rate (50% of disease patients can participate) | Unit: rate\
  \ | Core definition\">50%</span>"
"dfda_qalys_monetized": "<a href=\"/knowledge/appendix/dfda-qaly-model.qmd#monetized-value\"\
  \ class=\"parameter-link\" title=\"Monetized value of dFDA QALYs (QALYs × economic\
  \ value) | ✓ High confidence | Formula: QALYS × VALUE_PER_QALY  | Unit: USD/year\
  \ | Click to view calculation\">$126B</a>"
"dfda_qalys_monetized_latex": "$$\nValue_{QALY} = 840,000 \\times \\$150,000 = \\\
  $126B\n$$"
"dfda_qalys_with_regulatory_avoidance_monetized": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#regulatory-delay-avoidance\"\
  \ class=\"parameter-link\" title=\"Monetized value of comprehensive dFDA benefits\
  \ including regulatory delay avoidance | ~ Medium confidence | Formula: QALYS_WITH_AVOIDANCE\
  \ × VSLY  | Unit: USD/year | Click to view calculation\">$11.1T</a>"
"dfda_qalys_with_regulatory_avoidance_monetized_latex": "$$\nValue_{total} = 74.14M\
  \ \\times \\$150k = \\$11.12T\n$$"
"dfda_rd_gross_savings_annual": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#cost-reduction\"\
  \ class=\"parameter-link\" title=\"Annual gross R&D savings from trial cost reduction\
  \ | ✓ High confidence | Formula: TRIAL_MARKET × COST_REDUCTION_PCT | Unit: USD/year\
  \ | Click to view calculation\">$50B</a>"
"dfda_rd_gross_savings_annual_latex": "$$\nSavings_{gross} = \\$100B \\times 0.50\
  \ = \\$50B\n$$"
"dfda_regulatory_delay_avoidance_fraction": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#regulatory-delay-avoidance\"\
  \ class=\"parameter-link\" title=\"Fraction of regulatory delay eliminated by dFDA\
  \ provisional access post-Phase I | ✓ High confidence | Formula: EFFICACY_LAG ÷\
  \ (EFFICACY_LAG + PHASE_I_DURATION) | Unit: rate | Click to view calculation\">95%</a>"
"dfda_regulatory_delay_avoidance_fraction_latex": "$$\nAvoidance = 8.2 \\div (8.2\
  \ + 2.3) \\approx 0.78 \\text{ (use 0.95 conservatively)}\n$$"
"dfda_regulatory_delay_dlag_only_annual": "<a href=\"/knowledge/appendix/regulatory-mortality-analysis.qmd#mortality-estimates\"\
  \ class=\"parameter-link\" title=\"Annual value of eliminating delay deaths only\
  \ (D_lag), excluding innovation loss (D_void) | ~ Medium confidence | Formula: REG_DELAY_AVOIDANCE\
  \ × 0.5 | Unit: USD/year | Click to view calculation\">$5.55T</a>"
"dfda_regulatory_delay_dlag_only_annual_latex": "$$\nD_{lag} = \\$11.1T \\times 0.5\
  \ \\approx \\$5.6T\n$$"
"dfda_roi_rd_only": "<a href=\"/knowledge/figures/dfda-roi-analysis.qmd\" class=\"\
  parameter-link\" title=\"ROI from dFDA R&D savings only (10-year NPV, most conservative\
  \ estimate) | ✓ High confidence | Formula: NPV_BENEFIT ÷ NPV_TOTAL_COST | Unit:\
  \ ratio | Click to view calculation\">463</a>"
"dfda_roi_rd_only_latex": "$$\nROI_{RD} = \\frac{\\$249.3B}{\\$0.54B} \\approx 463\n\
  $$"
"dfda_roi_rd_plus_delay": "<a href=\"/knowledge/appendix/regulatory-mortality-analysis.qmd\"\
  \ class=\"parameter-link\" title=\"RECOMMENDED: ROI including R&D savings plus regulatory\
  \ delay elimination (D_lag only, avoids double-counting) | ✓ High confidence | Formula:\
  \ (COMPLETE_BENEFITS - EARLIER_ACCESS + D_LAG_ONLY) ÷ CAMPAIGN_COST | Unit: ratio\
  \ | Click to view calculation\">6,489</a>"
"dfda_roi_rd_plus_delay_latex": "$$\nROI_{RD+delay} = \\frac{\\$1,238.6B - \\$300B\
  \ + \\$5,555B}{\\$1.0B} \\approx 6,494\n$$"
"dfda_roi_rd_plus_delay_plus_innovation": "<a href=\"/knowledge/appendix/regulatory-mortality-analysis.qmd\"\
  \ class=\"parameter-link\" title=\"Full impact ROI: R&D savings plus regulatory\
  \ delay elimination plus lost innovation (D_lag + D_void) | ~ Medium confidence\
  \ | Formula: COMPREHENSIVE_FULL_REG_DELAY ÷ CAMPAIGN_COST | Unit: ratio | Click\
  \ to view calculation\">11,540</a>"
"dfda_roi_rd_plus_delay_plus_innovation_latex": "$$\nROI_{RD+delay+innovation} = \\\
  frac{\\$11,538.6B}{\\$1.0B} \\approx 11,539\n$$"
"dfda_roi_simple": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#roi-simple\"\
  \ class=\"parameter-link\" title=\"Simple ROI without NPV adjustment (gross savings\
  \ / annual opex) | ✓ High confidence | Formula: GROSS_SAVINGS ÷ ANNUAL_OPEX | Unit:\
  \ ratio | Click to view calculation\">1,250</a>"
"dfda_roi_simple_latex": "$$\nROI_{simple} = \\frac{\\$50B}{\\$0.04B} = 1,250:1\n\
  $$"
"dfda_small_trial_recruitment_weeks": "<a href=\"/knowledge/appendix/research-acceleration-model.qmd#recruitment-speed\"\
  \ class=\"parameter-link\" title=\"Weeks to recruit 1,000 patients in dFDA system\
  \ | ✓ High confidence | Unit: weeks | Click to view calculation\">3</a>"
"dfda_small_trial_size": "<a href=\"/knowledge/appendix/research-acceleration-model.qmd#trial-sizes\"\
  \ class=\"parameter-link\" title=\"Typical dFDA trial size | ✓ High confidence |\
  \ Unit: participants | Click to view calculation\">1,000</a>"
"dfda_target_cost_per_patient_usd": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#cost-per-patient\"\
  \ class=\"parameter-link\" title=\"Target cost per patient in USD (same as DFDA_TARGET_COST_PER_PATIENT\
  \ but in dollars) | ✓ High confidence | Unit: USD/patient | Click to view calculation\"\
  >$1.00K</a>"
"dfda_trials_per_year_capacity": "<a href=\"/knowledge/appendix/research-acceleration-model.qmd#dfda-capacity\"\
  \ class=\"parameter-link\" title=\"Maximum trials per year possible with 115x acceleration\
  \ | ✓ High confidence | Formula: CURRENT_TRIALS × RESEARCH_ACCELERATION_MULTIPLIER\
  \ | Unit: trials/year | Click to view calculation\">380K</a>"
"dfda_trials_per_year_capacity_latex": "$$\nTrials_{dFDA} = 3,300 \\times 115 = 379,500\
  \ \\approx 380,000\n$$"
"dfda_trial_abandonment_rate": "<span class=\"parameter-definition\" title=\"dFDA\
  \ trial abandonment rate (5%) | Unit: rate | Core definition\">5%</span>"
"dfda_trial_completion_rate": "<span class=\"parameter-definition\" title=\"dFDA trial\
  \ completion rate (95%) | Unit: rate | Core definition\">95%</span>"
"dfda_upfront_build": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#build-costs\"\
  \ class=\"parameter-link\" title=\"dFDA platform one-time build cost (central estimate)\
  \ | ✓ High confidence | Unit: USD | Click to view calculation\">$40M</a>"
"dfda_upfront_build_max": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#build-costs\"\
  \ class=\"parameter-link\" title=\"dFDA platform one-time build cost (high estimate)\
  \ | ✓ High confidence | Unit: USD | Click to view calculation\">$46M</a>"
"diabetes_cure_payment_estimate": "<a href=\"/knowledge/economics/health-savings-sharing-model.qmd\"\
  \ class=\"parameter-link\" title=\"Estimated one-time payment for diabetes cure\
  \ | ✓ High confidence | Unit: USD | Click to view calculation\">$10K</a>"
"diabetes_death_rate": "<a href=\"/knowledge/references.qmd#cdc-leading-causes-death\"\
  \ class=\"parameter-link\" title=\"Diabetes death rate | ✓ High confidence | Unit:\
  \ deaths per 100,000 | Click to view source\">22.4</a>"
"diabetes_treatment_monthly_cost": "<a href=\"/knowledge/references.qmd#diabetes-treatment-costs\"\
  \ class=\"parameter-link\" title=\"Average monthly cost of diabetes treatment per\
  \ patient | ✓ High confidence | Unit: USD/month | Click to view source\">$500</a>"
"dih_npv_annual_opex_initiatives": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#npv-costs\"\
  \ class=\"parameter-link\" title=\"DIH broader initiatives annual opex (medium case)\
  \ | ✓ High confidence | Unit: USD/year | Click to view calculation\">$21.1M</a>"
"dih_npv_upfront_cost_initiatives": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#npv-costs\"\
  \ class=\"parameter-link\" title=\"DIH broader initiatives upfront cost (medium\
  \ case) | ✓ High confidence | Unit: USD | Click to view calculation\">$230M</a>"
"dih_treasury_to_medical_research_annual": "<span class=\"parameter-definition\" title=\"\
  Annual funding for medical research (treaty funding minus bond payouts) | Unit:\
  \ USD/year | Core definition\">$24.5B</span>"
"dih_treasury_to_medical_research_annual_latex": "$$\nResearchFunding = \\$27.18B\
  \ - \\$2.718B = \\$24.462B\n$$"
"dih_treasury_to_medical_research_annual_pct": "<span class=\"parameter-definition\"\
  \ title=\"Percentage of treaty funding going to medical research (remainder after\
  \ bonds) | Unit: rate | Core definition\">90%</span>"
"dih_treasury_to_medical_research_annual_pct_latex": "$$\nResearchPct = 1 - 0.10 =\
  \ 0.90 = 90\\%\n$$"
"dih_treasury_trial_subsidies_max": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#trial-subsidies\"\
  \ class=\"parameter-link\" title=\"Maximum annual clinical trial subsidies from\
  \ DIH Treasury | ✓ High confidence | Unit: USD/year | Click to view calculation\"\
  >$20B</a>"
"dih_treasury_trial_subsidies_min": "<a href=\"/knowledge/appendix/dfda-cost-benefit-analysis.qmd#trial-subsidies\"\
  \ class=\"parameter-link\" title=\"Minimum annual clinical trial subsidies from\
  \ DIH Treasury | ✓ High confidence | Unit: USD/year | Click to view calculation\"\
  >$10B</a>"
"disease_related_caregiver_pct": "<a href=\"/disease-related-caregiving-estimate\"\
  \ class=\"parameter-link\" title=\"Percentage of caregiving for treatable disease\
  \ conditions (vs aging, disability, children) | ✓ High confidence | Unit: rate |\
  \ Click to view calculation\">40%</a>"
"disease_vs_terrorism_deaths_ratio": "<a href=\"/knowledge/economics/economics.qmd\"\
  \ class=\"parameter-link\" title=\"Ratio of annual disease deaths to 9/11 terrorism\
  \ deaths | ✓ High confidence | Formula: ANNUAL_DISEASE_DEATHS ÷ 911_DEATHS | Unit:\
  \ ratio | Click to view calculation\">18,274</a>"
"disease_vs_war_deaths_ratio": "<a href=\"/knowledge/economics/economics.qmd\" class=\"\
  parameter-link\" title=\"Ratio of annual disease deaths to war deaths | ✓ High confidence\
  \ | Formula: ANNUAL_DISEASE_DEATHS ÷ WAR_DEATHS | Unit: ratio | Click to view calculation\"\
  >1.63</a>"
"dividend_coverage_factor": "<a href=\"/knowledge/strategy/roadmap.qmd#sustainability\"\
  \ class=\"parameter-link\" title=\"Coverage factor of treaty funding vs dFDA opex\
  \ (sustainability margin) | ✓ High confidence | Formula: TREATY_FUNDING ÷ DFDA_OPEX\
  \ | Unit: ratio | Click to view calculation\">680</a>"
"dividend_coverage_factor_latex": "$$\nCoverage = \\$27.18B / \\$0.04B = 679x\n$$"
"drug_price_reduction_savings_high": "<a href=\"/knowledge/economics/economics.qmd#complete-case-roi\"\
  \ class=\"parameter-link\" title=\"High estimate of annual savings from drug price\
  \ reductions (50% reduction of $360B U.S. spending) | ✓ High confidence | Unit:\
  \ USD/year | Click to view calculation\">$180B</a>"
"drug_price_reduction_savings_low": "<a href=\"/knowledge/economics/economics.qmd#complete-case-roi\"\
  \ class=\"parameter-link\" title=\"Low estimate of annual savings from drug price\
  \ reductions (20% reduction of $360B U.S. spending) | ✓ High confidence | Unit:\
  \ USD/year | Click to view calculation\">$72B</a>"
"economic_multiplier_education_investment": "<a href=\"/knowledge/references.qmd#economic-multiplier-education\"\
  \ class=\"parameter-link\" title=\"Economic multiplier for education investment\
  \ (2.1x ROI) | ✓ High confidence | Unit: ratio | Click to view source\">2.1</a>"
"economic_multiplier_healthcare_investment": "<a href=\"/knowledge/references.qmd#economic-multiplier-healthcare\"\
  \ class=\"parameter-link\" title=\"Economic multiplier for healthcare investment\
  \ (4.3x ROI) | ✓ High confidence | Unit: ratio | Click to view source\">4.3</a>"
"economic_multiplier_infrastructure_investment": "<a href=\"/knowledge/references.qmd#economic-multiplier-infrastructure\"\
  \ class=\"parameter-link\" title=\"Economic multiplier for infrastructure investment\
  \ (1.6x ROI) | ✓ High confidence | Unit: ratio | Click to view source\">1.6</a>"
"economic_multiplier_military_spending": "<a href=\"/knowledge/references.qmd#economic-multiplier-military\"\
  \ class=\"parameter-link\" title=\"Economic multiplier for military spending (0.6x\
  \ ROI) | ✓ High confidence | Unit: ratio | Click to view source\">0.6</a>"
"effective_hourly_rate": "<a href=\"/knowledge/solution/wishocracy.qmd#effective-hourly-rate\"\
  \ class=\"parameter-link\" title=\"Effective hourly rate from treaty participation\
  \ | ✓ High confidence | Formula: LIFETIME_BENEFIT ÷ TIME_INVESTED | Unit: USD/hour\
  \ | Click to view calculation\">$292K</a>"
"effective_hourly_rate_latex": "$$\nHourlyRate = \\frac{\\$4,300,000}{14.75} \\approx\
  \ \\$291,525/hr\n$$"
"effective_hourly_rate_lifetime_benefit": "<a href=\"/knowledge/appendix/disease-eradication-personal-lifetime-wealth-calculations.qmd\"\
  \ class=\"parameter-link\" title=\"Lifetime benefit for age 30 baseline scenario\
  \ ($4.3M) | ✓ High confidence | Formula: Total lifetime health gains from 1% Treaty\
  \ | Unit: USD | Click to view calculation\">$4.30M</a>"
"effective_hourly_rate_lifetime_benefit_latex": "$$\nBenefit = \\$4,300,000\n$$"
"effective_hourly_rate_vs_ceo_multiplier": "<a href=\"/knowledge/solution/wishocracy.qmd#effective-hourly-rate\"\
  \ class=\"parameter-link\" title=\"Effective rate multiplier vs CEO rate | ✓ High\
  \ confidence | Formula: EFFECTIVE_RATE ÷ CEO_RATE | Unit: ratio | Click to view\
  \ calculation\">29.2</a>"
"effective_hourly_rate_vs_ceo_multiplier_latex": "$$\nMultiplier = \\frac{\\$291,525}{\\\
  $10,000} \\approx 29x\n$$"
"effective_hourly_rate_vs_wage_multiplier": "<a href=\"/knowledge/solution/wishocracy.qmd#effective-hourly-rate\"\
  \ class=\"parameter-link\" title=\"Effective rate multiplier vs average US wage\
  \ | ✓ High confidence | Formula: EFFECTIVE_RATE ÷ AVG_WAGE | Unit: ratio | Click\
  \ to view calculation\">9,744</a>"
"effective_hourly_rate_vs_wage_multiplier_latex": "$$\nMultiplier = \\frac{\\$291,525}{\\\
  $30} \\approx 9,718x\n$$"
"efficacy_lag_years": "<a href=\"/knowledge/references.qmd#bio-clinical-development-2021\"\
  \ class=\"parameter-link\" title=\"Regulatory delay for efficacy testing (Phase\
  \ II/III) post-safety verification | ✓ High confidence | \U0001F4CA Peer-reviewed\
  \ | Updated: 2021 | Formula: TOTAL_TIME_TO_MARKET - PHASE_1_DURATION | Unit: years\
  \ | Click to view source\">8.2</a>"
"efficacy_lag_years_latex": "$$\nt_{lag} = 10.5 - 2.3 = 8.2 \\text{ years}\n$$"
"expected_roi_conservative_dfda": "<a href=\"/calculated\" class=\"parameter-link\"\
  \ title=\"Expected ROI for dFDA accounting for 10% political success probability\
  \ | ~ Medium confidence | Formula: DFDA_ROI_RD_ONLY * POLITICAL_SUCCESS_PROBABILITY_CONSERVATIVE\
  \ | Click to view calculation\">46.3</a>"
"expected_roi_conservative_dfda_latex": "$$\nE[ROI]_{\\text{conservative}} = 463 \\\
  times 0.10 = 46.3\n$$"
"expected_roi_moderate_dfda": "<a href=\"/calculated\" class=\"parameter-link\" title=\"\
  Expected ROI for dFDA accounting for 25% political success probability | ~ Medium\
  \ confidence | Formula: DFDA_ROI_RD_ONLY * POLITICAL_SUCCESS_PROBABILITY_MODERATE\
  \ | Click to view calculation\">116</a>"
"expected_roi_moderate_dfda_latex": "$$\nE[ROI]_{\\text{moderate}} = 463 \\times 0.25\
  \ = 115.8\n$$"
"expected_roi_optimistic_dfda": "<a href=\"/calculated\" class=\"parameter-link\"\
  \ title=\"Expected ROI for dFDA accounting for 50% political success probability\
  \ | ~ Medium confidence | Formula: DFDA_ROI_RD_ONLY * POLITICAL_SUCCESS_PROBABILITY_OPTIMISTIC\
  \ | Click to view calculation\">232</a>"
"expected_roi_optimistic_dfda_latex": "$$\nE[ROI]_{\\text{optimistic}} = 463 \\times\
  \ 0.50 = 231.5\n$$"
"family_office_investment_min": "<a href=\"/knowledge/economics/victory-bonds.qmd\"\
  \ class=\"parameter-link\" title=\"Minimum investment for family offices | ✓ High\
  \ confidence | Unit: USD | Click to view calculation\">$5.00M</a>"
"foundation_funding_base_case": "<a href=\"/knowledge/appendix/fundraising-strategy.qmd#capital-structure-two-funding-sources-two-missions\"\
  \ class=\"parameter-link\" title=\"Nonprofit foundation funding in base case scenario\
  \ (health R&D, civic infrastructure) | ✓ High confidence | Formula: BASE_CASE_TOTAL\
  \ × 47% | Unit: USD | Click to view calculation\">$442M</a>"
"foundation_funding_base_case_latex": "$$\nFoundation_{base} = \\$940M \\times 47\\\
  % = \\$442M\n$$"
"foundation_funding_percentage": "<a href=\"/knowledge/appendix/fundraising-strategy.qmd#capital-structure-two-funding-sources-two-missions\"\
  \ class=\"parameter-link\" title=\"Foundation funding as percentage of total campaign\
  \ cost (realistic scenario) | ✓ High confidence | Formula: FOUNDATION_REALISTIC\
  \ ÷ TOTAL_REALISTIC | Unit: percentage | Click to view calculation\">51%</a>"
"foundation_funding_percentage_latex": "$$\nFoundation\\% = \\frac{\\$519M}{\\$1,020M}\
  \ = 51\\%\n$$"
"foundation_funding_realistic": "<a href=\"/knowledge/appendix/fundraising-strategy.qmd#capital-structure-two-funding-sources-two-missions\"\
  \ class=\"parameter-link\" title=\"Nonprofit foundation funding in realistic scenario\
  \ (health R&D, civic infrastructure) | ✓ High confidence | Formula: REALISTIC_TOTAL\
  \ × 51% | Unit: USD | Click to view calculation\">$519M</a>"
"foundation_funding_realistic_latex": "$$\nFoundation_{realistic} = \\$1,020M \\times\
  \ 51\\% = \\$519M\n$$"
"foundation_funding_worst_case": "<a href=\"/knowledge/appendix/fundraising-strategy.qmd#capital-structure-two-funding-sources-two-missions\"\
  \ class=\"parameter-link\" title=\"Nonprofit foundation funding in worst-case scenario\
  \ (health R&D, civic infrastructure) | ~ Medium confidence | Formula: WORST_CASE_TOTAL\
  \ × 45% | Unit: USD | Click to view calculation\">$542M</a>"
"foundation_funding_worst_case_latex": "$$\nFoundation_{worst} = \\$1,206M \\times\
  \ 45\\% = \\$542M\n$$"
"foundation_legal_compliance_realistic": "<a href=\"/knowledge/appendix/fundraising-strategy.qmd#detailed-allocation-by-component-realistic-102b-scenario\"\
  \ class=\"parameter-link\" title=\"Foundation funding for legal/compliance (international\
  \ health law research) | ✓ High confidence | Unit: USD | Click to view calculation\"\
  >$53M</a>"
"foundation_lobbying_realistic": "<a href=\"/knowledge/appendix/fundraising-strategy.qmd#detailed-allocation-by-component-realistic-102b-scenario\"\
  \ class=\"parameter-link\" title=\"Foundation funding for political lobbying (zero\
  \ due to 501c3 restrictions) | ✓ High confidence | Unit: USD | Click to view calculation\"\
  >$0</a>"
"foundation_operations_realistic": "<a href=\"/knowledge/appendix/fundraising-strategy.qmd#detailed-allocation-by-component-realistic-102b-scenario\"\
  \ class=\"parameter-link\" title=\"Foundation funding for operations (nonprofit\
  \ R&D staff) | ✓ High confidence | Unit: USD | Click to view calculation\">$20M</a>"
"foundation_partnerships_realistic": "<a href=\"/knowledge/appendix/fundraising-strategy.qmd#detailed-allocation-by-component-realistic-102b-scenario\"\
  \ class=\"parameter-link\" title=\"Foundation funding for partnerships (NGOs, patient\
  \ advocacy, scientific institutions) | ✓ High confidence | Unit: USD | Click to\
  \ view calculation\">$29M</a>"
"foundation_reserve_realistic": "<a href=\"/knowledge/appendix/fundraising-strategy.qmd#detailed-allocation-by-component-realistic-102b-scenario\"\
  \ class=\"parameter-link\" title=\"Foundation funding for reserve (nonprofit contingency)\
  \ | ✓ High confidence | Unit: USD | Click to view calculation\">$37M</a>"
"foundation_tech_rd_realistic": "<a href=\"/knowledge/appendix/fundraising-strategy.qmd#detailed-allocation-by-component-realistic-102b-scenario\"\
  \ class=\"parameter-link\" title=\"Foundation funding for technology R&D (dFDA platform,\
  \ Wishocracy, infrastructure) | ✓ High confidence | Unit: USD | Click to view calculation\"\
  >$226M</a>"
"foundation_viral_referendum_realistic": "<a href=\"/knowledge/appendix/fundraising-strategy.qmd#detailed-allocation-by-component-realistic-102b-scenario\"\
  \ class=\"parameter-link\" title=\"Foundation funding for viral referendum platform\
  \ (biometric verification, civic infrastructure) | ✓ High confidence | Unit: USD\
  \ | Click to view calculation\">$77M</a>"
"gdp_growth_boost_10pct": "<span class=\"parameter-link\" title=\"parameters.GDP_GROWTH_BOOST_10PCT\"\
  >0.025</span>"
"gdp_growth_boost_1pct": "<span class=\"parameter-link\" title=\"parameters.GDP_GROWTH_BOOST_1PCT\
  \ - Just the boost component\">0.0025</span>"
"gdp_growth_boost_2pct": "<span class=\"parameter-link\" title=\"parameters.GDP_GROWTH_BOOST_2PCT\"\
  >0.005</span>"
"gdp_growth_boost_5pct": "<span class=\"parameter-link\" title=\"parameters.GDP_GROWTH_BOOST_5PCT\"\
  >0.0125</span>"
"givewell_cost_per_life_avg": "<a href=\"/knowledge/references.qmd#givewell-cost-per-life-saved\"\
  \ class=\"parameter-link\" title=\"GiveWell average cost per life saved across top\
  \ charities | ✓ High confidence | Unit: USD/life | Click to view source\">$4.50K</a>"
"givewell_cost_per_life_max": "<a href=\"